Advisor Group Holdings, Inc. Syros Pharmaceuticals, Inc. Transaction History

Advisor Group Holdings, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$0.69 - $1.21 $2,159 - $3,787	3,130 Added 94.85%	6,430 $6,000
Q1 2022 May 04, 2022	BUY	$1.02 - $3.8 $2,917 - $10,868	2,860 Added 650.0%	3,300 $3,000
Q2 2021 Aug 02, 2021	BUY	$5.01 - $7.48 $200 - $299	40 Added 10.0%	440 $3,000
Q1 2021 May 13, 2021	BUY	$7.19 - $14.95 $2,157 - $4,485	300 Added 300.0%	400 $3,000
Q4 2020 Feb 10, 2021	SELL	$6.66 - $14.66 $3,663 - $8,063	-550 Reduced 84.62%	100 $1,000
Q1 2020 May 18, 2020	BUY	$4.46 - $9.2 $2,899 - $5,979	650 New	650 $4,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.